Imagine a mushroom so mysterious that it causes people to see tiny, fairy-like figures—dozens of miniature humans, elves, or creatures—dancing and crawling right on their dishes or around their surroundings. But here's where it gets controversial: scientists have only recently begun to understand this strange phenomenon, which appears consistently across different cultures and regions, yet remains largely unexplored and misunderstood.
Every year in the Yunnan Province of China, hospitals see a peculiar surge of patients complaining of vivid visions. These visions aren’t your typical hallucinations—they involve seeing small, elf-like beings marching, climbing walls, or perched on furniture, sometimes even on their clothing or food. Remarkably, most patients report that these tiny figures are strikingly similar across different cases, regardless of individual differences.
The common root of these bizarre experiences is a particular mushroom called Lanmaoa asiatica. This species often grows in pine forests in the region and is also a popular local delicacy, thanks to its rich, savory flavor—an umami bomb enjoyed at markets, restaurants, and homes during mushroom season, which peaks from June to August.
Caution is essential, though. Proper cooking is critical; undercooked L. asiatica can trigger these hallucinations. As Colin Domnauer, a doctoral student in biology at the University of Utah, recounts, at a local hot pot restaurant in Yunnan, waiters warned diners to cook the mushroom thoroughly, jokingly stating, 'Don’t eat it until the timer goes off or you might see little people.' This knowledge seems to be common within the local culture but is largely a mystery elsewhere.
Beyond this region, the mushroom’s effects and existence are shrouded in mystery. Numerous reports describe its psychoactive effects, yet the actual species has eluded scientific confirmation. Giuliana Furci, a mycologist and founder of the Fungi Foundation, notes that while many have searched for this mushroom, credible identification remains elusive—despite numerous anecdotal accounts.
Domnauer’s quest is to decode these mysteries: to conclusively identify the mushroom, determine what chemical compounds cause such consistent lilliputian hallucinations, and uncover what this could reveal about the human brain and consciousness.
His fascination started as a student. When introduced to L. asiatica, Domnauer was captivated by the idea of a mushroom that causes fairy-tale visions shared across diverse cultures and epochs. Scientific clues toward understanding this species are sparse. A 1991 paper from Chinese scientists described Chinese cases where people who consumed some unknown mushroom experienced tiny human and animal visions—a phenomenon called 'lilliputian hallucinations,' named after the tiny people from the novel 'Gulliver’s Travels.' Patients reported seeing these miniature beings moving around on their clothes, dishes, and even with their eyes closed, with images often more vivid during sleep.
Historical anecdotes extend further back. In the 1960s, explorers Gordon Wasson and Roger Heim encountered similar reports in Papua New Guinea—stories of locals experiencing 'mushroom madness' after consuming certain unidentified fungi. They collected mushroom samples and sent them to Albert Hofmann, the Swiss scientist who discovered LSD, expecting to find psychoactive compounds. But Hofmann couldn’t find any meaningful molecules, and the stories were dismissed as cultural legends.
It wasn’t until 2015 that scientists officially described and named Lanmaoa asiatica, although its psychoactive properties remain poorly understood. The mushroom doesn’t seem to contain psilocybin—the classic psychedelic compound in magic mushrooms—yet it produces extraordinary, long-lasting trips, sometimes lasting a day or more, and in extreme cases leading to hospitalization.
Domnauer's recent expeditions in 2023 took him deep into the markets of Yunnan, where he collected specimens based on local descriptions of 'the mushroom that makes you see little people.' Genetic sequencing of these samples confirmed their identity as L. asiatica. Laboratory tests using extracts from these mushrooms induced behavioral changes in mice that resemble human hallucination reports—hyperactivity followed by sluggishness.
He also traveled to the Philippines, where he found similar-looking specimens, smaller and lighter in color. Genetic analysis again confirmed they belonged to the same species, suggesting wide-ranging distribution. Conversely, efforts to locate the original Papua New Guinea species—where the story of 'mushroom insanity' first appeared—have yet to bear fruit, leaving the origin of these tiny-vision effects an unresolved puzzle.
An intriguing hypothesis is that if specimens from Papua New Guinea are different from those in China and the Philippines, it could mean that the lilliputian visions evolved independently in separate mushroom species, an example of convergent evolution. Such phenomena aren’t unprecedented; recent studies have shown that psychedelic molecules like psilocybin evolved separately in diverse mushroom lineages.
Crucially, the active compound in L. asiatica remains unidentified. Its effects are unique, with hallucinations lasting 12 to 24 hours—much longer than typical psychedelics—and can sometimes cause severe side effects. Because of these prolonged trips, Domnauer has refrained from ingesting the raw mushroom himself.
An interesting aspect of this phenomenon is its remarkable consistency. Unlike many psychedelics, which produce highly variable and personal experiences, the perception of tiny humans appears to be a reliably reported effect across different individuals and cultures. This consistency raises profound questions: why does this mushroom consistently trigger lilliputian visions, and what does this tell us about how our brains process hallucinations?
Studying L. asiatica isn’t just about understanding a strange fungus. It has the potential to answer some of the most fundamental questions about consciousness and perception. Moreover, it could shed light on related neurological conditions where spontaneous lilliputian hallucinations occur without any mushroom ingestion. Such cases are rare but often serious, with some patients never fully recovering.
Experts like Dennis McKenna believe that identifying the mushroom’s chemical makeup could open new doors for pharmacology and therapeutic development. Could there be novel compounds capable of treating mental health or neurological disorders? The ongoing research will determine that.
Beyond this, the discovery emphasizes the rich promise hidden within the world’s fungi, many species of which remain unknown—less than 5% of the estimated 2.2 million fungal species have been described. As Furci highlights, fungi harbor an enormous biochemical and pharmacological treasure trove, and ongoing exploration could revolutionize medicine, neuroscience, and our understanding of nature.
In summary, while the mystery of L. asiatica’s lilliputian hallucinations still challenges scientists, the journey to uncover its secrets could lead to groundbreaking insights into the brain, the evolution of psychedelic compounds, and the astonishing diversity of life that the fungal kingdom holds.
